Corvus Pharmaceuticals, Inc.
USD11.69
-0.39 (-3.23%)
CEO
Richard A. Miller
IPO Date
2016-03-23
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$11.88
Prev. Close
$12.08
Day Low
$11.44
Day High
$11.94
52W Low
$3.55
52W High
$26.95
Market Cap
$0.98B
Volume
1.91M
| 1,932 |
| $12.01 |
| 27 Apr 2026 | Chan Andrew C. | director | A-Award | Acquired | 30,000 | $16.02 |
| 27 Apr 2026 | Chan Andrew C. | — | Disposed | 0 | $0.00 |
| 30 Jan 2026 | Thompson Peter A. | director, 10 percent owner: | M-Exempt | Disposed | 15,000 | $1.64 |
| 30 Jan 2026 | Thompson Peter A. | director, 10 percent owner: | M-Exempt | Acquired | 15,000 | $12.50 |
| 30 Jan 2026 | Thompson Peter A. | director, 10 percent owner: | M-Exempt | Acquired | 15,000 | $2.74 |
| 30 Jan 2026 | Thompson Peter A. | director, 10 percent owner: | M-Exempt | Acquired | 15,000 | $2.60 |
| 30 Jan 2026 | Thompson Peter A. | director, 10 percent owner: | M-Exempt | Acquired | 15,000 | $0.99 |
| 30 Jan 2026 | Thompson Peter A. | director, 10 percent owner: | M-Exempt | Acquired | 15,000 | $0.96 |